Literature DB >> 17173255

Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.

Nina Babel1, Lelia Gabdrakhmanova, Markus H Hammer, Constanze Schoenemann, Volodimir Skrypnikov, Nina Poliak, Hans-Dieter Volk, Petra Reinke.   

Abstract

BACKGROUND: Cytokines play a crucial role in different immunopathological conditions. Cytokine secretion is reported to be determined by polymorphisms in the cytokine genes. Since TNF-alfa and IL-10 are involved in regulation of inflammation, and TGF-beta 1 can induce fibrosis and renal insufficiency - dominant features of end-stage renal disease (ESRD), we explored the hypothesis that polymorphisms of these cytokine genes may be possible genetic susceptibility factors for the progression of renal failure.
METHODS: We studied the IL-10 (-1082), TNF-alfa (-308), TGF-beta 1 (codon 10;25) gene single nucleotide polymorphisms in 118 healthy donors and 103 patients with ESRD (44 hemodialysis patients with diabetic nephropathy and 59 hemodialysis patients with glomerulonephritis) using PCR-SSP.
RESULTS: Significant associations of ESRD with the TGF-beta 1 (codon 10) TT (odds ratio [OR] = 5.31; 95% confidence interval [95% CI], 3.77-7.02; p<0.001) and IL-10 (-1082) GG (OR=2.35; 95% CI, 1.67-3.15; p<0.01) genotypes were found. Statistical analysis of genotype frequencies made separately for the underlying renal disease (diabetes or glomerulo-nephritis) revealed the same linkage trend: TGF-beta 1 (codon 10) TT and IL-10 (-1082) GG were associated with type 2 diabetic nephropathy (p<0.001 and p<0.05, respectively) and chronic glomerulonephritis (p<0.001 and p<0.01, respectively). No significant differences in the TNF-alfa , TGF-beta 1 (codon 25) genotype distribution between healthy controls and patients with diabetic nephropathy- or glomerulonephritis-associated ESRD were detected.
CONCLUSIONS: Carriage of the TGF-beta 1 (codon 10) TT and IL-10 (-1082) GG genotypes may increase susceptibility to ESRD in German patients with type 2 diabetes or glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173255

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  11 in total

1.  Association of Transforming Growth Factor Beta-1 (TGF-β1) Genetic Variation with Type 2 Diabetes and End Stage Renal Disease in Two Large Population Samples from North India.

Authors:  Priyanka Raina; Ruhi Sikka; Ramandeep Kaur; Jasmine Sokhi; Kawaljit Matharoo; Virinder Singh; A J S Bhanwer
Journal:  OMICS       Date:  2015-04-14

2.  Association between TNF-α -308G/A polymorphism and diabetic nephropathy risk: a meta-analysis.

Authors:  Yuliang Zhao; Jiqiao Yang; Ling Zhang; Zheng Li; Yingying Yang; Yi Tang; Ping Fu
Journal:  Int Urol Nephrol       Date:  2013-06-21       Impact factor: 2.370

3.  Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.

Authors:  Qingfeng Yin; Qianqian Zhai; Di Wang; Jie Hai; Meng Cao; Jianling Wang; Tao Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 4.  An association between IL-10 promoter polymorphisms and diabetic nephropathy: a meta-analysis of case-control studies.

Authors:  Norah Htet Htet; Arun Kumar Basavaraj; Cho Naing; Sivalingam Nalliah
Journal:  J Diabetes Metab Disord       Date:  2018-09-01

5.  Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes Patients.

Authors:  K F Rodrigues; N T Pietrani; V C Sandrim; C M A F Vieira; A P Fernandes; A A Bosco; K B Gomes
Journal:  J Diabetes Res       Date:  2015-05-06       Impact factor: 4.011

6.  Interleukin-10-1082A/G polymorphism and diabetic nephropathy: a meta-analysis.

Authors:  Xia Peng; Jiayun Xu; Pengpeng Wang; Jinjin Zhou; Hong Guo
Journal:  Med Sci Monit       Date:  2015-03-25

7.  Association of rs1800471 polymorphism of TGFB1 gene with chronic kidney disease occurrence and progression and hypertension appearance.

Authors:  Katarzyna Nabrdalik; Janusz Gumprecht; Piotr Adamczyk; Sylwia Górczyńska-Kosiorz; Joanna Zywiec; Władysław Grzeszczak
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

Review 8.  Developments in renal pharmacogenomics and applications in chronic kidney disease.

Authors:  Ariadna Padullés; Inés Rama; Inés Llaudó; Núria Lloberas
Journal:  Pharmgenomics Pers Med       Date:  2014-08-28

9.  African vs. Caucasian and Asian difference for the association of interleukin-10 promotor polymorphisms with type 2 diabetes mellitus (a meta-analysis study).

Authors:  Mohammad Tarabay; Rami Elshazli; Ahmad Settin
Journal:  Meta Gene       Date:  2016-03-04

Review 10.  The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis.

Authors:  Emily H Steen; Xinyi Wang; Swathi Balaji; Manish J Butte; Paul L Bollyky; Sundeep G Keswani
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-02-07       Impact factor: 4.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.